Abstract |
Approaches of targeting excessive activation and differentiation of osteoclasts were considered as an effective treatment option for osteoporosis or osteopenia. In the present work, a series of rhein derivatives were synthesized and employed for their cytotoxicity screening against bone marrow-derived macrophages cells (BMMs) and their inhibition effects on osteoclasts activation and differentiation in vitro using an MTT assay and a TRAP activity assay respectively. Two rhein derivatives d6 and d11 inhibited BMMs activation and differentiation with 98% and 85% inhibitory activity respectively, without showing any cytotoxicity on BMMs. Subsequently, the most potent compound d6 was further validated for its inhibitory effects on the formation of TRAP-positive multinucleated cells and bone resorption as evaluated by TRAP staining and bone resorption assay. The regulation by d6 of osteoclast marker genes assay revealed that treatment of BMMs with M-CSF and RANKL resulted in the stimulation of mRNA expressions of NFATc1, c-fos, TRAP, MMP-9 and cathepsin K which were highly related with osteoclast activation and differentiation, while d6 decreased mRNA expressions of these genes. It was indicated that d6 might regulate osteoclasts activity through RANKL/RANK/NFATc1 pathway. Thus our current work is expected to provide a highly promising approach for the development of a new type of anti- osteoporosis agent.
|
Authors | Xing Xu, Xueyu Qi, Yufei Yan, Jin Qi, Niandong Qian, Lei Guo, Changwei Li, Fei Wang, Ping Huang, Hanbing Zhou, Min Jiang, Chunhao Yang, Lianfu Deng |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 123
Pg. 769-776
(Nov 10 2016)
ISSN: 1768-3254 [Electronic] France |
PMID | 27541260
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Amides
- Anthraquinones
- Biomarkers
- NFATC Transcription Factors
- RANK Ligand
- rhein
|
Topics |
- 3T3-L1 Cells
- Amides
(chemistry)
- Animals
- Anthraquinones
(chemistry, pharmacology, therapeutic use)
- Biomarkers
(metabolism)
- Bone Marrow Cells
(cytology)
- Bone Resorption
(drug therapy, metabolism, pathology)
- Cell Differentiation
(drug effects)
- Chemistry Techniques, Synthetic
- Macrophages
(cytology, drug effects, metabolism)
- Male
- Mice
- NFATC Transcription Factors
(metabolism)
- Osteoclasts
(cytology, drug effects)
- RANK Ligand
(pharmacology)
|